Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer

PURPOSE: To investigate the clinical value of (18)F-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA)

Bibliographic Details
Published in:European journal of nuclear medicine and molecular imaging, Vol. 39, No. 6 (2012), p. 936-43
Main Author: Soyka, Jan D
Other Involved Persons: Muster, Marco A ; Schmid, Daniel T ; Seifert, Burkhardt ; Schick, Ulrike ; Miralbell, Raymond ; Jorcano, Sandra ; Zaugg, Kathrin ; Seifert, Hans-Helge ; Veit-Haibach, Patrick ; Strobel, Klaus ; Schaefer, Niklaus G ; Husarik, Daniela B ; Hany, Thomas F
Format: electronic Article
Language:English
ISSN:1619-7070
Item Description:Date Completed 05.09.2012
Date Revised 13.11.2018
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.1007/s00259-012-2083-2
Subjects:
QR Code: Show QR Code